The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 17, 2022
Filed:
Oct. 05, 2017
Applicant:
Bayer Pharma Aktiengesellschaft, Berlin, DE;
Inventors:
Peter Kolkhof, Wuppertal, DE;
Peter Sandner, Wuppertal, DE;
Assignee:
BAYER PHARMA AKTIENGESELLSCHAFT, Berlin, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); A61K 31/4375 (2006.01); A61K 45/06 (2006.01); A61K 31/167 (2006.01); A61K 31/4365 (2006.01); A61P 9/00 (2006.01); A61P 13/12 (2006.01); A61P 11/00 (2006.01); A61K 31/192 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4375 (2013.01); A61K 31/167 (2013.01); A61K 31/192 (2013.01); A61K 31/4365 (2013.01); A61K 45/06 (2013.01); A61P 9/00 (2018.01); A61P 11/00 (2018.01); A61P 13/12 (2018.01);
Abstract
The present invention relates to the combination of activators of soluble guanylate cyclase (sGC activators) with mineralocorticoid receptor antagonists (MR antagonists) and to the use of the combination for the treatment and/or prophylaxis of cardiac and cardiovascular disorders, of renal and cardiorenal disorders, of pulmonary and cardiopulmonary disorders and also for the treatment and/or prophylaxis of fibrotic disorders.